- Home
- INUV vs MNOV Comparison
INUV vs MNOV Comparison
Compare INUV & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- MNOV
- Stock Information
- Founded
- INUV N/A
- MNOV 2000
- Country
- INUV United States
- MNOV United States
- Employees
- INUV N/A
- MNOV N/A
- Industry
- INUV Advertising
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- INUV Consumer Discretionary
- MNOV Health Care
- Exchange
- INUV Nasdaq
- MNOV Nasdaq
- Market Cap
- INUV 62.8M
- MNOV 68.2M
- IPO Year
- INUV N/A
- MNOV 2005
- Fundamental
- Price
- INUV $3.48
- MNOV $1.30
- Analyst Decision
- INUV Strong Buy
- MNOV Strong Buy
- Analyst Count
- INUV 2
- MNOV 2
- Target Price
- INUV $2.00
- MNOV $7.00
- AVG Volume (30 Days)
- INUV 148.4K
- MNOV 10.2K
- Earning Date
- INUV 08-07-2025
- MNOV 08-07-2025
- Dividend Yield
- INUV N/A
- MNOV N/A
- EPS Growth
- INUV N/A
- MNOV N/A
- EPS
- INUV N/A
- MNOV N/A
- Revenue
- INUV $93,478,114.00
- MNOV N/A
- Revenue This Year
- INUV $28.36
- MNOV N/A
- Revenue Next Year
- INUV $12.18
- MNOV N/A
- P/E Ratio
- INUV N/A
- MNOV N/A
- Revenue Growth
- INUV 18.20
- MNOV N/A
- 52 Week Low
- INUV $1.90
- MNOV $1.12
- 52 Week High
- INUV $7.90
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- INUV 42.03
- MNOV 32.85
- Support Level
- INUV $3.00
- MNOV $1.25
- Resistance Level
- INUV $3.80
- MNOV $1.34
- Average True Range (ATR)
- INUV 0.34
- MNOV 0.04
- MACD
- INUV -0.05
- MNOV -0.01
- Stochastic Oscillator
- INUV 43.64
- MNOV 4.55
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.